China SXT Pharmaceuticals, Inc. (SXTC) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 | Q1'21 |
|---|
| Cash from Operations | -494.08K | -494.08K | -678.59K | -678.59K | -674.24K | -674.24K | -289.78K | -289.78K | 234.18K | 234.18K | -274.56K | -274.56K | 580.64K | 290.32K | -312.35K | -156.18K | -983.05K | -491.53K | -333.51K | -166.75K |
| Operating CF Margin % | -108.42% | -108.42% | -163.62% | -163.62% | -136.36% | -136.36% | -30.84% | -61.68% | 30.68% | 61.35% | -22.72% | -45.45% | -5.05% | 36.88% | -30.39% | -30.39% | 10.54% | -107.19% | -17.28% | -8.64% |
| Operating CF Growth % | 26.72% | 26.72% | -134.17% | -134.17% | -387.91% | -387.91% | -5.54% | -5.54% | -59.67% | -19.34% | 12.1% | -75.8% | 159.07% | 159.07% | 6.34% | 6.34% | -132.54% | -133.23% | 82.09% | 83.52% |
| Net Income | -1.25M | -1.25M | -401.28K | -401.28K | 3.3M | 3.3M | -4.85M | -4.85M | -2.22M | -2.22M | -747.3K | -747.3K | -2.64M | -1.32M | -3.09M | -1.55M | -4.13M | -2.06M | 1.38M | 690.63K |
| Depreciation & Amortization | 223.05K | 223.05K | 78.5K | 78.5K | 90.28K | 90.28K | 157.73K | 51.38K | 70.1K | 70.1K | 54.98K | 54.98K | 134.01K | 67K | 186K | 93K | 162.49K | 81.24K | 182.93K | 91.46K |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 176.05K | 176.05K | 0 | 0 | 138.64K | 138.64K | 138.64K | 138.64K | 1M | 1M | 162.89K | 162.89K | 0 | 0 | 0 | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 750.5K | -845.84K | -163.52K | 0 | 2.37K | 0 | 325.78K | 0 | -284.17K | 0 | 91.48K | 0 |
| Other Non-Cash Items | 411.91K | 411.91K | 186.62K | 186.62K | -3.91M | -3.91M | 4.25M | 4.36M | 1.54M | 1.54M | 299.22K | 299.22K | 3.93M | 960.65K | -913.55K | -264.58K | 1.76M | 996.48K | 3.24M | 85.69K |
| Working Capital Changes | 121.51K | 121.51K | -542.42K | -542.42K | -325.96K | -325.96K | 149.03K | 149.03K | 709.48K | 709.48K | -20.1K | -20.1K | -909.55K | -419.5K | 2.81M | 1.4M | 825.16K | 495.47K | -2.43M | -1.03M |
| Change in Receivables | 23.09K | 23.09K | -151.63K | -151.63K | -124.23K | -124.23K | -36.48K | -36.48K | 642.84K | 642.84K | -186.37K | -186.37K | 98.59K | 66.83K | 697.8K | 348.9K | 1.03M | 514.58K | -1.53M | -774.2K |
| Change in Inventory | 225.81K | 225.81K | -376.99K | -376.99K | -75.87K | -75.87K | -19.28K | -19.28K | 64.36K | 64.36K | 140.19K | 140.19K | 268.88K | 134.44K | 31.24K | 15.62K | -51.78K | -25.89K | -250.74K | -125.37K |
| Change in Payables | 0 | 0 | 0 | 0 | 0 | 0 | 19.35K | 0 | -244.28K | 0 | 253.97K | 0 | -34.38K | 0 | 11.59K | 0 | 26.32K | 0 | -645.85K | 0 |
| Cash from Investing | 11.49K | 11.49K | 20.27K | 20.27K | 3.39K | 3.39K | 9.82K | 9.82K | -25.81K | -25.81K | 19.66K | 19.66K | 9.26M | 4.63M | -9.3M | -4.65M | -8.54M | -4.27M | 2.74M | 1.37M |
| Capital Expenditures | -1.01K | -1.01K | 0 | 0 | -3.53K | -3.53K | 0 | 0 | -25.28K | -25.28K | -10.06K | -10.06K | -41.35K | -20.68K | -21.14K | -10.57K | 26.17K | 13.09K | -119.22K | -59.61K |
| CapEx % of Revenue | 0.22% | 0.22% | - | - | 0.71% | 0.71% | - | - | 3.31% | 6.62% | 0.83% | 1.66% | -0.36% | 2.63% | 2.06% | 2.06% | -0.28% | 2.85% | 6.18% | 3.09% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 12.5K | 12.5K | 20.27K | 20.27K | 6.92K | 6.92K | 9.82K | 9.82K | -523 | -523 | 29.71K | 29.71K | 9.3M | 4.65M | -9.28M | -4.64M | 3.13M | -4.28M | 1.43M | 1.43M |
| Cash from Financing | 580.99K | 580.99K | 3.62M | 3.62M | 918.65K | 918.65K | -2.23M | -2.23M | 7.01M | 7.01M | -5.53M | -5.53M | 5.5M | 2.75M | -3.91M | -1.95M | 12.13M | 6.07M | 274.5K | 137.25K |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 580.99K | 580.99K | 3.62M | 3.62M | 918.65K | 918.65K | -2.23M | -2.23M | 7.01M | 7.01M | -5.53M | -5.53M | 5.5M | 2.75M | -3.91M | -1.95M | 12.13M | 6.07M | 274.5K | 137.25K |
| Net Change in Cash | 0 | 0 | 0 | 0 | 306.08K | 306.08K | -5.9M | -2.95M | 14.39M | 4.21M | -12.59M | -6.29M | 15.54M | 7.77M | -13.33M | -6.66M | 3.01M | 1.5M | 3.07M | 1.53M |
| Free Cash Flow | -495.09K | -495.09K | -678.59K | -678.59K | -677.77K | -677.77K | -289.78K | -289.78K | 208.9K | 208.9K | -284.62K | -284.62K | 539.29K | 269.65K | -333.49K | -166.74K | -956.88K | -478.44K | -452.73K | -226.36K |
| FCF Margin % | -108.64% | -108.64% | -163.62% | -163.62% | -137.07% | -137.07% | -30.84% | -61.68% | 27.36% | 54.73% | -23.56% | -47.11% | -4.69% | 34.25% | -32.45% | -32.45% | 10.26% | -104.34% | -23.45% | -11.73% |
| FCF Growth % | 26.95% | 26.95% | -134.17% | -134.17% | -424.45% | -424.45% | -1.81% | -1.81% | -61.26% | -22.53% | 14.65% | -70.69% | 156.36% | 156.36% | 26.34% | 26.34% | -132.02% | -132.71% | 79.75% | 81.12% |
| FCF per Share | -0.20 | -0.20 | -1.68 | -1.68 | -0.55 | -0.78 | -0.58 | -0.58 | 0.48 | 0.48 | -2.78 | -2.78 | 10.35 | 5.18 | -10.72 | -5.36 | -33.24 | -16.62 | -15.73 | -7.87 |
| FCF Conversion (FCF/Net Income) | 0.40x | 0.40x | 1.69x | 1.69x | -0.20x | -0.20x | 0.03x | 0.06x | -0.05x | -0.11x | 0.18x | 0.37x | 0.25x | -0.22x | 0.10x | 0.10x | -0.19x | 0.24x | -0.48x | -0.24x |
| Interest Paid | -700 | -700 | 11.32K | 11.32K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |